Sushil Agrawala

The relentless march of antimicrobial resistance (AMR) has emerged as a public health concern, especially in the light of the fact that newer antibiotic classes have been slow to develop and investments in novel antimicrobial drug classes have been receding. AMR problem transcends international borders with antibiotic stewardship. Increasing thrust for restriction on AGP’s has instigated h ...